ACD - a Bio-Techne brand, (www.acdbio.com) shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and tissue-based research and diagnostic tests for personalized medicine. Based in Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry. ACD’s products and pharma assay services are based on its proprietary RNAscope™ technology ( 10,000+ publications), the first multiplex fluorescent and chromogenic in situ hybridization platform, capable of detecting and quantifying single molecules of RNA in situ. ACD has two product lines, namely RNAscope and BaseScope™ in addition to a Professional Assay Services business. The catalog includes >50,000 target probes and assay kits for single, duplex and multiplex RNA analysis. www.acdbio.com
Looking for a particular Advanced Cell Diagnostics employee's phone or email?
Advanced Cell Diagnostics Questions
The Advanced Cell Diagnostics annual revenue was $7 million in 2026.
Steve Chen is the COO of Advanced Cell Diagnostics.
125 people are employed at Advanced Cell Diagnostics.
Advanced Cell Diagnostics is based in Newark, California.
The NAICS codes for Advanced Cell Diagnostics are [54, 5417, 54171, 541, 541714].
The SIC codes for Advanced Cell Diagnostics are [873, 87].
Top Advanced Cell Diagnostics Employees
-
Steve Chen
COO at Advanced Cell Diagnostics
Fremont, CA, US15+ -
21
-
Paul Liu
Senior Product Manager at Advanced Cell Diagnostics
Alameda, CA, US15 -
Li Fang
Senior Account Executive at Advanced Cell Diagnostics
San Mateo, CA, US34 -
13
-
22
-
23
Related Companies
